Produkty 5241-24-7

CAS 5241-24-7 występuje w naszej ofercie pod nazwami: Cholesterol Impurity 24, Demethyldihydrolanosterol, Dihydro T-MAS. Oferty producentów: Hubei YoungXin, TRC, MedChemExpress. Dostępne opakowania: 10mg, 25mg, 50mg, 100mg, 200mg, 1mg, 1 mg, 5 mg.

Cholesterol Impurity 24
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
Demethyldihydrolanosterol
TRC
  • opakowanie: 10mg, 1mg
  • Warianty: 2
Zobacz produkt
Dihydro T-MAS
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 4870,81
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5R,10S,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol (CAS 5241-24-7) to związek chemiczny o wzorze sumarycznym C29H50O i masie molowej 414.7 g/mol. Nazwa systematyczna IUPAC: (3S,5R,10S,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol. InChIKey: FYHRVINOXYETMN-QGBOJXOESA-N.

Dane identyfikacyjne
Wzór sumarycznyC29H50O
Masa molowa414.7 g/mol
Nazwa IUPAC(3S,5R,10S,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol
InChIKeyFYHRVINOXYETMN-QGBOJXOESA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Demethyldihydrolanosterol, 4,4-Dimethyl-5alpha-cholest-8-en-3beta-ol, 4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol, 4,4-Dimethyl-5a-cholesta-8-en-3b-ol, 4,4-dimethylcholest-8(9)-en-3beta-ol, 4,4-dimethylcholesta-8(9)-en-3beta-ol, 3beta-hydroxy-4,4-dimethyl-8(9)-cholestene, 3beta-hydroxy-4,4-dimethylcholest-8(9)-ene, 4,4-dimethyl-3beta-hydroxy-8(9)-cholestene, 4,4-dimethyl-3beta-hydroxycholest-8(9)-ene
Izomery (ten sam wzór sumaryczny)
(3S,8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C29H50O
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H50O
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H50O
(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C29H50O